Bayer: a bitter pill to swallow

Credit of the month

com-1-gif

Bayer has been shaken by widespread litigation concerning its ill-fated anti-cholesterol drug, Baycol. Despite winning its first major US court case, in Corpus Christi, Texas, a factor that softened market sentiment towards Bayer, future lawsuits are still a big thorn in the German company’s side. The victory does set a favourable precedent, but the decision should not be viewed as the end of Bayer’s troubles, as each individual case differs in its circumstances.

The German pharmaceuticals compan

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: